Amdocs (NASDAQ:DOX – Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.859-7.116 for the period, compared to the consensus EPS estimate of 6.970. The company issued revenue guidance of $4.4 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q2 2025 guidance to 1.670-1.730 EPS.
Analyst Ratings Changes
DOX has been the subject of a number of recent research reports. Barclays dropped their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a report on Tuesday, January 14th. Finally, Oppenheimer increased their price objective on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $101.20.
Get Our Latest Research Report on Amdocs
Amdocs Stock Performance
Amdocs (NASDAQ:DOX – Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 9.85% and a return on equity of 18.69%. On average, analysts expect that Amdocs will post 6.19 EPS for the current fiscal year.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st were given a $0.479 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a yield of 2.21%. Amdocs’s dividend payout ratio (DPR) is 45.28%.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
- Five stocks we like better than Amdocs
- The Basics of Support and Resistance
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- There Are Different Types of Stock To Invest In
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.